Evaluation of the efficacy and safety of favipiravir and interferon compared to lopinavir/ritonavir and interferon in moderately ill patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial

Peer Review reports

Original Submission
10 Sep 2020	Submitted	Original manuscript
11 Sep 2020	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
16 Sep 2020	Editorially accepted
27 Oct 2020	Article published	10.1186/s13063-020-04747-8

Back to article page